{'52WeekChange': 0.44186056,
 'SandP52WeekChange': 0.0644362,
 'address1': '140 Intracoastal Pointe Drive',
 'address2': 'Suite 404',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 9.43,
 'askSize': 800,
 'averageDailyVolume10Day': 161862,
 'averageVolume': 285400,
 'averageVolume10days': 161862,
 'beta': 0.493557,
 'beta3Year': None,
 'bid': 8,
 'bidSize': 1800,
 'bookValue': 1.247,
 'category': None,
 'circulatingSupply': None,
 'city': 'Jupiter',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 9.1,
 'dayLow': 8.52,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': 129.875,
 'enterpriseValue': 207010352,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '561-743-8343',
 'fiftyDayAverage': 8.645429,
 'fiftyTwoWeekHigh': 10.98,
 'fiftyTwoWeekLow': 2.51,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 17960159,
 'forwardEps': 0.23,
 'forwardPE': 37.717392,
 'fromCurrency': None,
 'fullTimeEmployees': 6,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.30187,
 'heldPercentInstitutions': 0.16256,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/dyadic.com',
 'longBusinessSummary': 'Dyadic International, Inc., a biotechnology platform '
                        'company, develops, produces, and sells enzymes and '
                        'other proteins in the United States. The company '
                        'utilizes its patented and proprietary C1 technology '
                        'and other technologies to conduct research, '
                        'development, and commercial activities for the '
                        'development and manufacturing of human and animal '
                        'vaccines and drugs, such as virus like particles and '
                        'antigens, monoclonal antibodies, fab antibody '
                        'fragments, Fc-fusion proteins, biosimilars and/or '
                        'biobetters, and other therapeutic proteins. It has a '
                        'research and development agreement with VTT Technical '
                        'Research Centre of Finland, Ltd., as well as with the '
                        'Israel Institute for Biological Research; strategic '
                        'research services agreement with Biotechnology '
                        'Developments for Industry in Pharmaceuticals, S.L.U.; '
                        'research collaboration with Sanofi-Aventis '
                        'Deutschland GmbH; research and commercialization '
                        'collaboration with Serum Institute of India Pvt.; and '
                        'nonexclusive research collaboration with WuXi '
                        'Biologics. Dyadic International, Inc. was founded in '
                        '1979 and is headquartered in Jupiter, Florida.',
 'longName': 'Dyadic International, Inc.',
 'market': 'us_market',
 'marketCap': 238295312,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_4272801',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -8346846,
 'nextFiscalYearEnd': 1640908800,
 'open': 9.07,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '561-743-8333',
 'previousClose': 9.02,
 'priceHint': 2,
 'priceToBook': 6.9566965,
 'priceToSalesTrailing12Months': 149.5026,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 9.1,
 'regularMarketDayLow': 8.52,
 'regularMarketOpen': 9.07,
 'regularMarketPreviousClose': 9.02,
 'regularMarketPrice': 9.07,
 'regularMarketVolume': 134205,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 27469200,
 'sharesPercentSharesOut': 0.063,
 'sharesShort': 1729874,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1145399,
 'shortName': 'Dyadic International, Inc.',
 'shortPercentOfFloat': 0.090100005,
 'shortRatio': 4.05,
 'startDate': None,
 'state': 'FL',
 'strikePrice': None,
 'symbol': 'DYAI',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.307,
 'twoHundredDayAverage': 6.3371944,
 'volume': 134205,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.dyadic.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '33477'}